SIGKNOW BIOMEDICAL INDEPENDENTLY DEVELOPS WORLD LEADING DIAGNOSTIC TECHNIQUES AND TOOLS
LIFE SCIENCE AND HEART RHYTHM CARE
Founded in 2014, Sigknow Biomedicals first product was EZYPRO® ECG Recorder—a medical grade product for 14-day long-term ECG monitoring. EZYPRO® assists doctors in confirming the diagnosis of arrhythmia, helps patients receive timely treatments, and prevents severe complications such as stroke and heart failure. EZYPRO® also helps doctors to ensure surgical efficiency after cardiac surgeries or catheter ablation.
BIG DATA AND MACHINE LEARNING
Sigknow Biomedicals professional software team independently developed an ECG analysis software, which has been certified by the TFDA. The software is equipped with built-in algorithms to accurately identify ECG signals. By using big data analysis with AI machine learning, in combination with professionals at the ECG analysis center, the software provides accurate analysis reports that assist cardiologists in making arrhythmia diagnosis and devising precise treatment options for patients.
ELECTRONICS, HARDWARE, AND SOFTWARE
Sigknow Biomedical combines its expertise in electronics, hardware, and software to independently develop innovative diagnostic tools. The first product EZYPRO® ECG Recorder has been licensed by TFDA, and it is adopted by major medical centers. The fecal occult blood test product that is still under development has won the National Innovation Award in 2017. The product is expected to be released in 2019.